IM Cannabis Appoints Asi Levi as Chief Financial Officer

Rhea-AI Summary

IM Cannabis (Nasdaq: IMCC) appointed Asi Levi, CPA as Chief Financial Officer effective December 12, 2025, replacing Uri Birenberg.

Mr. Levi has over 15 years of finance experience, including prior CFO roles at Water Ways Technologies and DekelOil CI and controller roles at SciSparc and A2Z Cust2Mate. The company said he oversaw fundraising, financial planning, budgeting and cash flow management under IFRS and other standards. The company thanked Mr. Birenberg for his service and wished him success in future endeavors.

Positive

• New CFO appointment effective December 12, 2025
• 15+ years of finance and controlling experience
• Prior CFO roles at Water Ways Technologies and DekelOil CI
• IFRS experience in fundraising and financial planning

Negative

• Immediate CFO replacement may create short-term transition risk

Key Figures

Finance experience over 15 years Asi Levi’s experience in finance and controlling roles

Market Reality Check

$1.88 Last Close

Volume Volume 50,757 vs 20-day average 122,312 suggests limited pre-news positioning. low

Technical Shares at $1.67, trading below 200-day MA of $2.08, indicating a pressured longer-term trend.

Peers on Argus

Peers show mixed moves (FLGC -7.56%, BFRI +0.87%, others modestly up/down), suggesting this CFO news is more company-specific than sector-driven.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 13	Q3 2025 earnings	Negative	-9.0%	Weak margins, higher expenses, net loss and going concern disclosure.
Nov 06	Earnings date notice	Neutral	-0.8%	Announcement of timing for Q3 2025 financial and operational results.
Oct 29	CFO departure	Neutral	+0.0%	CFO stepping down for personal reasons with planned transition period.
Oct 23	Acquisition term sheet	Positive	-9.7%	Non-binding deal to buy 60% of quantum computing bio data company.
Sep 16	Board and strategy	Positive	+1.6%	New board members and chairman plus pursuit of additional opportunities.

Pattern Detected

Recent news with financial or strategic implications (Q3 results, quantum computing acquisition term sheet) coincided with notable negative price reactions, while governance changes drew modest or flat responses.

Recent Company History

Over the last few months, IM Cannabis has reported flat Q3 2025 revenue of $13.9M with weaker margins and a $3.9M net loss, alongside a going concern note and regulatory headwinds in Germany. The company announced a non-binding term sheet to acquire a 60% stake in a quantum computing bio data firm for up to $54M, and made multiple governance moves, including board reshuffling and the prior CFO departure. Today’s CFO appointment continues this management transition theme.

Regulatory & Risk Context

Active S-3 Shelf Registration 2025-06-26

$50 million registered capacity

The company has an effective Form F-3 shelf from June 26, 2025, allowing issuance of up to $50 million in securities, providing flexibility to raise capital via common shares, warrants or units over time. No usage has been recorded yet in the provided context.

Market Pulse Summary

This announcement finalizes IM Cannabis’s CFO transition by appointing Asi Levi, a CPA with over 15 years in finance and controlling roles and experience in fundraising, budgeting, and IFRS compliance. It follows Q3 results that included weaker margins and a going concern note, as well as strategic initiatives like the quantum computing bio data term sheet. Investors may watch how the new CFO addresses cost control, cash management, and any future use of the $50 million F-3 shelf.

Key Terms

international financial reporting standards (IFRS) financial

"cash flow management in compliance with international financial reporting standards (IFRS)"

A set of globally accepted accounting rules companies use to prepare financial statements so their numbers speak the same language across borders. For investors, IFRS matters because it makes it easier to compare profitability, assets and liabilities between companies the way a common recipe or measuring tape lets you judge two cakes or two rooms fairly, which helps assess value and risk more reliably.

IFRS financial

"cash flow management in compliance with international financial reporting standards (IFRS)"

International Financial Reporting Standards (IFRS) are a set of common accounting rules used by many companies worldwide to prepare financial statements, so numbers like revenue, profit and assets are measured in the same way across borders. For investors, IFRS matters because it makes it easier to compare the financial health and performance of different companies—like using the same ruler to measure different objects—reducing surprises and helping informed investment decisions.

AI-generated analysis. Not financial advice.

TORONTO and GLIL YAM, Israel, Dec. 12, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced, further to its press release dated October 29, 2025, the appointment of Asi Levi, CPA, as the Company's Chief Financial Officer ("CFO"), effective immediately, to replace Uri Birenberg.

Mr. Levi has over 15 years of experience in finance and controlling roles, including serving as Chief Financial Officer of Water Ways Technologies Inc. and DekelOil CI, part of Dekel Agri-Vision Plc and as Controller of SciSparc Ltd. and A2Z Cust2Mate Solutions Corp. He has overseen fundraising efforts and handled financial planning, budgeting, and cash flow management in compliance with international financial reporting standards (IFRS) and other standards.

The Company thanks Mr. Birenberg for his contributions during his tenure as CFO and wishes him success in his future endeavors. 

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
info@imcannabis.com

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/im-cannabis-appoints-asi-levi-as-chief-financial-officer-302640165.html

SOURCE IM Cannabis Corp.

FAQ

Who is the new CFO of IM Cannabis (IMCC) as of December 12, 2025?

Asi Levi, CPA was appointed Chief Financial Officer effective December 12, 2025.

Which executive did Asi Levi replace at IM Cannabis (IMCC)?

Asi Levi replaced Uri Birenberg as Chief Financial Officer.

What relevant experience does IM Cannabis CFO Asi Levi have for IMCC investors?

He has over 15 years in finance, prior CFO roles and IFRS experience in fundraising and planning.

When did IM Cannabis announce the appointment of its new CFO (IMCC)?

The appointment was announced on December 12, 2025 and is effective immediately.

Will the IM Cannabis CFO change (IMCC) affect financial reporting processes?

The company highlighted Asi Levi's IFRS experience, indicating continuity in international reporting practices.